诺沃·诺迪斯克基金会承诺从2026年到2035年向哥本哈根的生物技术、AI和量子创新BII认捐736M美元。 Novo Nordisk Foundation pledges $736M to Copenhagen’s BII for biotech, AI, and quantum innovation from 2026 to 2035.

新诺尔茨克基金会承诺从2026年到2035年向哥本哈根生物创新研究所(BII)认捐多达55亿丹麦克朗(约7.36亿欧元),将支持范围从生物技术扩大到AI和量子技术。 The Novo Nordisk Foundation has pledged up to DKK 5.5 billion (about EUR 736 million) to Copenhagen’s BioInnovation Institute (BII) from 2026 to 2035, expanding support beyond biotech into AI and quantum technology. 这笔资金旨在扩大BII平台的规模,帮助启动130多个新创办企业,吸引超过70亿丹麦克朗的外部投资,同时加强欧洲科技创新能力。 The funding aims to scale BII’s platform, which has helped launch over 130 start-ups and attract more than DKK 7 billion in external investment, while strengthening Europe’s innovation capacity in science and technology.